Mike Maloney: Gold, Silver Bull Run in Final Phase, I Expect “Spectacular” Prices
Mike Maloney, founder of GoldSilver.com, explains why this time really is different for gold and silver, pointing to factors including growing mainstream
Mike Maloney, founder of GoldSilver.com, explains why this time really is different for gold and silver, pointing to factors including growing mainstream
Cyprium Metals (CYM:AU) has announced Senior Loan Facility Refinanced with Nebari Download the PDF here. This post appeared first on investingnews.com
As its record-setting year continues, gold is on its way to posting its strongest annual performance since 1979, up an impressive 58
Mid-tier precious metals producer Americas Gold and Silver (TSX:USA,NYSEAMERICAN:USAS) continues to grow its North American footprint with its intended acquisition of privately
Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (‘ Copper Quest ‘ or the ‘ Company ‘) is pleased to
Peter Schiff, chief economist and global strategist at Euro Pacific Asset Management and founder of Schiff Gold, shares his outlook on gold
Chris Marcus, founder of Arcadia Economics, shares his thoughts on silver and gold. While it’s impossible to know exactly how precious metals
Regardless of how the gold price is doing, the top gold-mining companies are always making moves. Right now, gold is in the limelight
Development-ready gold asset in premier mining jurisdiction with funded advancement plan; preparing to initiate project-development and exploration drill program Fortune Bay Corp. (TSXV:
Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large Rossing-style target ReeXploration Inc. (TSXV: REE) (FSE: K2I0)
Osisko Metals Incorporated (the ‘ Company or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to announce that Sorbie Bornholm LP (‘Sorbie’),
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division —